Contracts › 75N95024F00001
75N95024F00001: Screening of Investigational Agents Through the Ninds Preclinical Screening Platform for Pain (PSPP)
Awarded to Psychogenics Inc. by National Institutes of Health (NIH).
$36.0Mobligated
$65.8Mpotential value
05 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N95024F00001 |
|---|---|
| Vehicle | 75N95024D00038 |
| Awardee | Psychogenics Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | NJ |
| Period of performance | 06 September 2024 to 05 September 2027 |
| Potential end | 05 September 2029 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record